Audio By Carbonatix
AstraZeneca Plc said a “careful” review of all available data of the more than 17 million people in the European Union and the U.K. it has vaccinated against so far against Covid-19 shows no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia.
The company says it is continually monitoring the safety of its vaccine.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
MTN Ghana webinar urges SMEs to get financial discipline right
25 minutes -
Duvor Klu, Hua crowned champions as J30 Accra Week 1 concludes
38 minutes -
Gov’t to make rural telephony services cheaper by first quarter of 2027 – Sam George
1 hour -
National Chief Imam remains Ghana’s strongest symbol of interfaith harmony – Mahama Ayariga
1 hour -
Gov’t to upgrade all rural telephony networks to 4G capability – Sam George
2 hours -
‘We’ve never seen a CJ in our judiciary system who is everywhere like MTN’ – Janet Nabla
2 hours -
Lawyers, prosecutors fume over abandoned 26-year-old Upper West High court project
2 hours -
At least two dead in blast at Bolivia military barracks
2 hours -
Tate brothers officially indicted with trafficking and sex crimes in Romania
2 hours -
US envoys arrive in Moscow ahead of Ukraine talks
2 hours -
Health Minister to brief media on Free Primary Healthcare programme on Monday
3 hours -
‘It was inappropriate to make that comparison’ – Dr Pumpuni Asante on CJ’s SOE comment
3 hours -
Photos: Final-day shopping continues at Joy FM Back-to-School Discount Fair
3 hours -
Darkey and Frimpong set up J30 Accra boys’ doubles final
3 hours -
When war takes more than territory: The human cost of conflict
3 hours